• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿中头孢曲松的药代动力学

Ceftriaxone pharmacokinetics in newborn infants.

作者信息

McCracken G H, Siegel J D, Threlkeld N, Thomas M

出版信息

Antimicrob Agents Chemother. 1983 Feb;23(2):341-3. doi: 10.1128/AAC.23.2.341.

DOI:10.1128/AAC.23.2.341
PMID:6301369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC186052/
Abstract

Ceftriaxone pharmacokinetics were determined in 40 newborn infants who were 1 to 45 days of age. Mean peak plasma concentrations of 136 to 173 micrograms/ml were observed at the completion of a 15-min intravenous infusion of 50 mg of ceftriaxone per kg. Mean half-life values were 5.2 to 8.4 h, and mean plasma clearances were 0.7 to 1.8 ml/min. Rectal swab cultures from 14 of 16 infants had either reduced numbers of aerobic and anaerobic bacteria or no growth during therapy. A once-daily dosage schedule is suggested for ceftriaxone therapy in newborn infants.

摘要

在40名年龄为1至45天的新生儿中测定了头孢曲松的药代动力学。在每千克静脉注射50毫克头孢曲松15分钟结束时,观察到平均血浆峰值浓度为136至173微克/毫升。平均半衰期值为5.2至8.4小时,平均血浆清除率为0.7至1.8毫升/分钟。16名婴儿中有14名的直肠拭子培养物在治疗期间需氧菌和厌氧菌数量减少或无生长。建议对新生儿进行头孢曲松治疗时采用每日一次的给药方案。

相似文献

1
Ceftriaxone pharmacokinetics in newborn infants.新生儿中头孢曲松的药代动力学
Antimicrob Agents Chemother. 1983 Feb;23(2):341-3. doi: 10.1128/AAC.23.2.341.
2
Pharmacokinetics of cefotaxime in newborn infants.头孢噻肟在新生儿中的药代动力学
Antimicrob Agents Chemother. 1982 Apr;21(4):683-4. doi: 10.1128/AAC.21.4.683.
3
Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.头孢曲松在患脑膜炎儿科患者中的药代动力学。
Antimicrob Agents Chemother. 1983 Feb;23(2):191-4. doi: 10.1128/AAC.23.2.191.
4
Single-dose ceftriaxone kinetics in the newborn.新生儿单剂量头孢曲松的动力学
Clin Pharmacol Ther. 1985 May;37(5):522-8. doi: 10.1038/clpt.1985.82.
5
Ceftriaxone--clinical experience in the treatment of neonates.
J Infect. 1985 Jul;11(1):25-33. doi: 10.1016/s0163-4453(85)90926-0.
6
Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.头孢曲松在患脑膜炎的新生儿和婴儿中的药代动力学。
J Pediatr. 1984 Sep;105(3):475-81. doi: 10.1016/s0022-3476(84)80032-3.
7
Concentrations of ceftriaxone in serum and gynecological tissues.血清和妇科组织中头孢曲松的浓度。
Chemotherapy. 1983;29(2):153-5. doi: 10.1159/000238189.
8
Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.静脉输注和肌内注射后头孢曲松的药代动力学
Am J Med. 1984 Oct 19;77(4C):112-6.
9
Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.头孢曲松治疗小儿细菌性脑膜炎的药代动力学及脑脊液杀菌活性
Antimicrob Agents Chemother. 1982 Oct;22(4):622-7. doi: 10.1128/AAC.22.4.622.
10
Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys.YM-13115、头孢曲松和头孢他啶在大鼠、犬和恒河猴体内的比较药代动力学
Antimicrob Agents Chemother. 1984 Aug;26(2):204-7. doi: 10.1128/AAC.26.2.204.

引用本文的文献

1
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling.预测新生儿的分布容积:基于生理学的药代动力学建模的性能
Pharmaceutics. 2023 Sep 19;15(9):2348. doi: 10.3390/pharmaceutics15092348.
2
Ceftriaxone Administration Associated with Lithiasis in Children: Guilty or Not? A Systematic Review.儿童使用头孢曲松与结石形成的相关性:是否有罪?一项系统评价
J Pers Med. 2023 Apr 16;13(4):671. doi: 10.3390/jpm13040671.
3
Safety of ceftriaxone in paediatrics: a systematic review protocol.头孢曲松在儿科中的安全性:系统评价方案。
BMJ Open. 2017 Aug 21;7(8):e016273. doi: 10.1136/bmjopen-2017-016273.
4
Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates.基于药代动力学-药效学的抗菌药物剂量优化用于治疗新生儿革兰氏阴性菌感染的证据评估。
Indian J Med Res. 2017 Mar;145(3):299-316. doi: 10.4103/ijmr.IJMR_723_15.
5
Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.一名28日龄婴儿因硬膜外血肿接受紧急开颅手术时对头孢曲松的不良反应:新生儿胆汁假性结石的综述
Ther Clin Risk Manag. 2015 Jul 2;11:1035-41. doi: 10.2147/TCRM.S79419. eCollection 2015.
6
Pharmacokinetics of cephalosporins in the neonate: a review.头孢菌素类药物在新生儿中的药代动力学:综述。
Clinics (Sao Paulo). 2011;66(7):1267-74. doi: 10.1590/s1807-59322011000700024.
7
Evaluation of a potential clinical interaction between ceftriaxone and calcium.评价头孢曲松与钙之间的潜在临床相互作用。
Antimicrob Agents Chemother. 2010 Apr;54(4):1534-40. doi: 10.1128/AAC.01111-09. Epub 2010 Jan 19.
8
A perspective on new beta-lactam antibiotics in pediatric patients.儿科患者新型β-内酰胺类抗生素的前景
Bull N Y Acad Med. 1984 May;60(4):374-9.
9
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
10
Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children.每日一次给予头孢曲松治疗儿童脑膜炎及其他严重感染。
Eur J Clin Microbiol. 1983 Oct;2(5):509-15. doi: 10.1007/BF02013918.

本文引用的文献

1
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.羟羧氧酰胺菌素(LY127935)、奈替米星和氨苄西林在实验性革兰阴性肠道杆菌性脑膜炎中的药代动力学及细菌学疗效
Antimicrob Agents Chemother. 1980 Mar;17(3):406-11. doi: 10.1128/AAC.17.3.406.
2
Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.头孢他啶在实验性肺炎链球菌、流感嗜血杆菌和大肠杆菌脑膜炎中的药代动力学及细菌学效应
Antimicrob Agents Chemother. 1983 Feb;23(2):213-7. doi: 10.1128/AAC.23.2.213.
3
Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.头孢曲松治疗小儿细菌性脑膜炎的药代动力学及脑脊液杀菌活性
Antimicrob Agents Chemother. 1982 Oct;22(4):622-7. doi: 10.1128/AAC.22.4.622.
4
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.羟羧氧酰胺菌素、头孢噻肟、头孢哌酮和头孢曲松在实验性细菌性脑膜炎中的药代动力学及细菌学疗效
J Infect Dis. 1981 Feb;143(2):156-63. doi: 10.1093/infdis/143.2.156.
5
In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.儿科患者革兰氏阴性杆菌对羟羧氧酰胺菌素、头孢噻肟、Ro 13-9904及其他头孢菌素的体外敏感性
Antimicrob Agents Chemother. 1980 Sep;18(3):476-9. doi: 10.1128/AAC.18.3.476.
6
Drug therapy. Clinical Pharmacokinetics (first of two parts).药物治疗。临床药代动力学(两部分中的第一部分)。
N Engl J Med. 1975 Oct 2;293(14):702-5. doi: 10.1056/NEJM197510022931406.